Saturday - May 24, 2025

LOGIN  |  REGISTER
Assertio

BUY $ASRT

Buy $ASRT on Charles Schwab

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Assertio to Report First Quarter 2025 Financial Results on May 12, 2025

May 05, 2025 | Last Trade: US$0.70 0.0073 -1.03

LAKE FOREST, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release first quarter 2025 financial results on Monday, May 12, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and update the Company’s 2025 strategic plans.

To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx. Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial +1-646-307-1963. The call ID is 3278948.

A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.

About Assertio

Assertio is a commercial pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.

Investor Contact
Matt Kreps
Darrow Associates Investor Relations
+1-214-597-8200
mkreps@darrowir.com  

BUY $ASRT

Buy $ASRT on Charles Schwab

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Stock Quote

BUY $ASRT

Buy $ASRT on Charles Schwab

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...

CLICK TO LEARN MORE
Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page